Searchable abstracts of presentations at key conferences in endocrinology

ea0077p107 | Reproductive Endocrinology | SFEBES2021

A randomised controlled trial on the effect of very-low-calorie diet (VLCD) vs. an energy deficit diet, in women with the polycystic ovary syndrome (PCOS) – remission PCOS

Deshmukh Harshal , Papageorgiou Maria , Wells Liz , Akbar Shahzad , Strudwick Tom , Reid Marie , Sathyapalan Thozhukat

PCOS is the most common endocrine disorder affecting the women of reproductive age group and weight loss is the mainstay of management of PCOS. We performed an open-label randomised controlled trial to compare the effects of a conventional energy deficit approach (-600 kcal/day of the total energy requirements) vs. a very low-calorie diet (VLCD: 800 kcal/day) on free androgen index (FAI), body weight, and metabolic markers in women with PCOS. Forty-one eligible patients were r...

ea0050p323 | Obesity and Metabolism | SFEBES2017

A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome

Javed Zeeshan , Kilpatrick Eric , Mann Vincent , Corless Lynsey , Abouda George , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) has been linked to non-alcoholic fatty liver disease (NAFLD) that carries an increased risk of liver cirrhosis. The Enhanced Liver Fibrosis (ELF) score comprises serum hyaluronic acid (HA), procollagen III N-terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase-1 (TIMP1) that correlate with hepatic fibrosis staging.Objective: To determine the effect of vitamin D suppleme...

ea0050p323 | Obesity and Metabolism | SFEBES2017

A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome

Javed Zeeshan , Kilpatrick Eric , Mann Vincent , Corless Lynsey , Abouda George , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) has been linked to non-alcoholic fatty liver disease (NAFLD) that carries an increased risk of liver cirrhosis. The Enhanced Liver Fibrosis (ELF) score comprises serum hyaluronic acid (HA), procollagen III N-terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase-1 (TIMP1) that correlate with hepatic fibrosis staging.Objective: To determine the effect of vitamin D suppleme...

ea0044p182 | Obesity and Metabolism | SFEBES2016

Concentrations of endocrine disrupting chemicals in liver and adipose tissue in United Kingdom

Sathyapalan Thozhukat , Aylward Lesa , Rose Martin , Petch Steve , Thatcher Natalie , Atkin Stephen

The prevalence of obesity is increasing in most populations. The aim of this study was to provide baseline data on the concentrations of chlorinated and brominated dioxins and related compounds as well as polybrominated diphenyl ethers to assess whether concentrations of these compounds are higher in obese than control subjects.Materials and Methods: Patients undergoing Roux-en-y gastric bypass surgery for weight loss and control patients who were underg...

ea0044p199 | Obesity and Metabolism | SFEBES2016

Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with PCOS

Sathyapalan Thozhukat , Javed Zeeshan , Kilpatrick Eric S , Coady Anne-Marie , Atkin Stephen L

Context: There is growing evidence that cannabinoid receptor-1 (CB-1) blockade reduces inflammation and neovascularization by decreasing vascular endothelial growth factor (VEGF) levels associated with a reduction in inflammatory markers, thereby potentially reducing cardiovascular risk.Objective: To determine the impact of CB1 antagonism by rimonabant on VEGF and inflammatory markers in obese PCOS women.Design: Randomised, open-la...

ea0044p206 | Reproduction | SFEBES2016

The effects of Vitamin D on the outcomes of controlled ovarian stimulation in women with and without Polycystic Ovary Syndrome undergoing in vitro fertilisation

Cunningham Thomas , Allgar Victoria , Atkin Stephen , Kilpatrick Eric , Maguiness Stephen , Sathyapalan Thozahukat

Background: Vitamin D deficiency has become the most common nutritional deficiency throughout the world. 67–85% of Polycystic Ovary Syndrome (PCOS) patients have low serum levels of Vitamin D. Studies have reported conflicting data as to whether or not Vitamin D may play a role in human reproduction. The objective of this prospective cohort study was to investigate what effect vitamin D had on parameters within an in vitro fertilisation (IVF) cycle in a populatio...

ea0044p216 | Reproduction | SFEBES2016

Androsterone Glucuronide to dehydroepiandrosterone sulphate ratio is higher in obese Caucasian women with Polycystic Ovary Syndrome

Sathyapalan Thozhukat , Ahmed Lina , Keevil Brian , Miller Adrian , Kilpatrick Eric , Atkin Stephen

Objective: Androsterone glucuronide (ADTG) concentrations have been suggested as a more reliable marker of the effects of androgens at the target tissue level and they are significantly elevated in hirsute compared to non-hirsute women with PCOS. This study compared the different precursors of testosterone, including dehydroepiandrosterone sulphate (DHEAS), ADTG and androstenedione in non-obese compared to obese women with PCOS, and in normal subjects and their implications on...

ea0044p217 | Reproduction | SFEBES2016

A prospective cohort study investigating Endocrine Disrupting Agents and Polycystic Ovary Syndrome within an IVF setting

Cunningham Thomas , Allgar Victoria , Atkin Stephen , Kilpatrick Eric , Maguiness Stephen , Sathyapalan Thozahukat

Background: Endocrine Disrupting Agents (EDAs) are external substances that have the potential to interfere with the natural endocrine pathways such as the reproductive axis. Polycystic ovary syndrome (PCOS) is a common endocrine condition resulting in, hyperinsulinaemia, hyperandrogenaemia and subfertility. This study was conducted to see whether there was any association between EDAs and PCOS.Methods: Blood samples were collected from 59 women (29 PCOS...

ea0059p156 | Obesity & metabolism | SFEBES2018

Randomised trial of empagliflozin versus metformin in polycystic ovary syndrome

Javed Zeeshan , Papageorgiou Maria , Kilpatrick Eric , Abbas Jehangir , Khan Amer , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Background: Empagliflozin is a sodium-glucose-cotransporter-2 that improves cardiovascular risk and weight loss in patients with type 2 diabetes. Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular risk; therefore, empagliflozin may be of benefit in PCOS.Methods: A randomised, open-label study in 40 overweight and obese women with PCOS treated with either empagliflozin 25 mg or metformin 1500mg daily for 12 weeks....

ea0038p246 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

The effect of soy protein with and without isoflavones in men with type 2 diabetes mellitus and subclinical hypogonadism: a randomised double-blind parallel study

Sathyapalan Thozhukat , Thatcher Natalie J , Rigby Alan S , Kilpatrick Eric S , Atkin Stephen L

Isoflavones are a subgroup of phytoestrogens and have a chemical structure similar to oestrogen, leading to concerns regarding possible adverse effects of isoflavones in men. Testosterone levels in men with type 2 diabetes mellitus (T2DM) are lower.Materials and methods: A randomised double-blind, parallel study was undertaken with 200 men with T2DM, of median age of 50 years (25th/75th centiles; 50, 55) years with a total testosterone level ≤12 nm...